Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer

Completed · Phase 3

Conditions studied: Breast Cancer, Metastases

In brief

The purpose of this clinical trial is to determine if RPR109881 is a better treatment than capecitabine (Xeloda) for advanced breast cancer in patients that no longer benefit from docetaxel and/or paclitaxel.

Key facts

Study ID

NCT00081796

Run by

Sanofi

People needed

438

Starts

2004-04-01

Expected to finish

2006-09-01

Last updated by the study team

2008-08-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Study site — Tucson, Arizona, United States
• Study site — Little Rock, Arkansas, United States
• Study site — Bakersfield, California, United States
• Study site — Burbank, California, United States
• Study site — Concord, California, United States
• Study site — Fountain Valley, California, United States
• Study site — Fresno, California, United States
• Study site — Fullerton, California, United States
• Study site — Gilroy, California, United States
• Study site — Long Beach, California, United States
• Study site — Los Angeles, California, United States
• Study site — Monterey Park, California, United States
• Study site — Northridge, California, United States
• Study site — Oxnard, California, United States
• Study site — Pomona, California, United States
• Study site — Porterville, California, United States
• Study site — Redondo Beach, California, United States
• Study site — San Diego, California, United States
• Study site — San Francisco, California, United States
• Study site — Santa Barbara, California, United States
• Study site — Soquel, California, United States
• Study site — Vista, California, United States
• Study site — New London, Connecticut, United States
• Study site — Newark, Delaware, United States
• Study site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.